NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS” or the "Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...
H.C. Wainwright analyst Raghuram Selvaraju increased the price target on Replimune Group (NASDAQ:REPL), currently trading at $13.79 with a market cap of $1.06 billion, to $22.00, up from the previous ...
25m
U.S. applications for unemployment benefits fell last week as employers continue to retain workers despite resurgent ...
Q2 2025 Earnings Call Transcript February 12, 2025 ReposiTrak, Inc. misses on earnings expectations. Reported EPS is $0.08 EPS, expectations were $0.09. Operator: Greetings, and welcome to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback